Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LuCaFab (ITM-31)
i
Other names:
ITM-31, CAXII-targeting 177Lu radiolabeled antibody Fab fragment, Lu-177 labeled 6A10-Fab-fragments
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
German Research Center for Environmental Health, ITM Isotopen Technologien Munchen
Drug class:
Ionizing radiation emitter, Carbonic anhydrase XII inhibitor
Related drugs:
‹
177Lu-satetraxetan-lilotomab (4)
lutetium Lu 177 vipivotide tetraxetan (4)
ibritumomab tiuxetan (3)
AAA614 (2)
Actinium-225 conjugated to daratumumab (2)
lutetium Lu 177 dotatate (2)
PNT2002 (2)
radium Ra-223 dichloride (2)
CLR 131 (2)
TLX250 (0)
177Lu-DTPA-omburtamab (0)
177Lu-LNC1003 (0)
177Lu-LNC1004 (0)
177Lu-LNC1010 (0)
177Lu-P17-087 (0)
177Lu-P17-088 (0)
177Lu-PSMA-R2 (0)
CYT 500 (0)
TLX591 (0)
90Y-NM600 (0)
TLX66 (0)
AAA603 (0)
iodine I 131 tositumomab (0)
CAM-H2 (0)
samarium-153 DOTMP (0)
Debio 0228 (0)
EBTATE (0)
FF21101 (0)
epratuzumab Y-90 (0)
MVT-1075 (0)
186Re (0)
Radspherin (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
177Lu-edotreotide (0)
Re (0)
177Lu-satetraxetan-lilotomab (4)
lutetium Lu 177 vipivotide tetraxetan (4)
ibritumomab tiuxetan (3)
AAA614 (2)
Actinium-225 conjugated to daratumumab (2)
lutetium Lu 177 dotatate (2)
PNT2002 (2)
radium Ra-223 dichloride (2)
CLR 131 (2)
TLX250 (0)
177Lu-DTPA-omburtamab (0)
177Lu-LNC1003 (0)
177Lu-LNC1004 (0)
177Lu-LNC1010 (0)
177Lu-P17-087 (0)
177Lu-P17-088 (0)
177Lu-PSMA-R2 (0)
CYT 500 (0)
TLX591 (0)
90Y-NM600 (0)
TLX66 (0)
AAA603 (0)
iodine I 131 tositumomab (0)
CAM-H2 (0)
samarium-153 DOTMP (0)
Debio 0228 (0)
EBTATE (0)
FF21101 (0)
epratuzumab Y-90 (0)
MVT-1075 (0)
186Re (0)
Radspherin (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
177Lu-edotreotide (0)
Re (0)
›
Associations
News
Trials
Filter by
Latest
12ms
RIT in GBM: Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment (clinicaltrials.gov)
P1, N=15, Recruiting, University Hospital Muenster | Initiation date: Oct 2022 --> Jun 2023
12 months ago
Trial initiation date
|
LuCaFab (ITM-31)
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login